Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

22 results
Display

The Advantage of an Endoscopic Submucosal Tunneling Technique for Rectal Carcinoid Tumors

Kobara H, Mori H, Chei L, Fujihara S, Nishiyama , Masaki T

  • Gut Liver.
  • 2017 Sep;11(5):735-737.
  • doi: 10.5009/gnl16580
Endoscopic treatment can be a curative option for small carcinoid tumors with an extremely low risk of metastasis. Since most carcinoid tumors are characterized by a specific growth pattern in...
Active Helicobacter pylori Infection Is a Risk Factor for Colorectal Mucosa: Early and Advanced Colonic Neoplasm Sequence

Kountouras J, Kapetanakis N, Polyzos SA, Katsinelos P, Gavalas E, Tzivras D, Zeglinas C, Kountouras C, Vardaka E, Stefanidis E, Kazakos E

  • Gut Liver.
  • 2017 Sep;11(5):733-734.
  • doi: 10.5009/gnl16389
No abstract available.
Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer

Chung JW, Chung MJ, Bang S, Park SW, Song SY, Chung JB, Park JY

  • Gut Liver.
  • 2017 Sep;11(5):728-732.
  • doi: 10.5009/gnl16526
BACKGROUND/AIMS: We aimed to investigate the incidence of second primary pancreatic cancer (PC) after colorectal cancer (CRC) and to identify risk factors associated with subsequent PC. METHODS: The observed incidence of...
Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naïve or Treatment-Experienced

Lee HW, Yoo KY, Won JW, Kim HJ

  • Gut Liver.
  • 2017 Sep;11(5):721-727.
  • doi: 10.5009/gnl17209
BACKGROUND/AIMS: Chronic hepatitis C (CHC) is a major comorbidity in patients with hemophilia. METHODS: Patients (n=30) were enrolled between September 2015 and April 2016. Twenty-six patients were genotype 1 (1b, n=21;...
Real-World Single-Center Experience with Sofosbuvir-Based Regimens for the Treatment of Chronic Hepatitis C Genotype 1 Patients

Shin HP, Burman B, Kozarek RA, Zeigler A, Wang C, Lee H, Zehr T, Edwards AM, Siddique A

  • Gut Liver.
  • 2017 Sep;11(5):711-720.
  • doi: 10.5009/gnl16447
BACKGROUND/AIMS: The approval of sofosbuvir (SOF), a direct-acting antiviral, has revolutionized the treatment of chronic hepatitis C virus (HCV). METHODS: We assessed the sustained virological response (SVR) of SOF-based regimens in...
Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study

Lim YL, Kim MY, Jang YO, Baik SK, Kwon SO

  • Gut Liver.
  • 2017 Sep;11(5):702-710.
  • doi: 10.5009/gnl16478
BACKGROUND/AIMS: Non-selective beta blockers (NSBBs) are currently the only accepted regimen for preventing portal hypertension (PHT)-related complications. However, the effect of NSBBs is insufficient in many cases. Bacterial translocation (BT)...
Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation

Lee HW, Kim HS, Kim SU, Kim DY, Kim BK, Park JY, Ahn SH, Jeon MY, Heo JY, Park SY, Lee YR, Jang SK, Lee SH, Jang SY, Tak WY, Han KH

  • Gut Liver.
  • 2017 Sep;11(5):693-701.
  • doi: 10.5009/gnl16391
BACKGROUND/AIMS: Limited information is available regarding patient survival after sorafenib discontinuation in patients with hepatocellular carcinoma (HCC). Thus, we developed and validated a novel survival prediction model. METHODS: Clinical data from...
Nomograms to Predict the Individual Survival of Patients with Solitary Hepatocellular Carcinoma after Hepatectomy

Shen J, He L, Li C, Wen T, Chen W, Lu C, Yan L, Li B, Yang J

  • Gut Liver.
  • 2017 Sep;11(5):684-692.
  • doi: 10.5009/gnl16465
BACKGROUND/AIMS: Solitary hepatocellular carcinoma (HCC) is a subgroup of HCCs. We aimed to establish nomograms for predicting the survival of solitary HCC patients after hepatectomy. METHODS: A total of 538 solitary...
Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease

Hayashi T, Saitoh S, Fukuzawa K, Tsuji Y, Takahashi , Kawamura Y, Akuta N, Kobayashi , Ikeda K, Fujii T, Miyati T, Kumada H

  • Gut Liver.
  • 2017 Sep;11(5):674-683.
  • doi: 10.5009/gnl16440
BACKGROUND/AIMS: Noninvasive liver fibrosis evaluation was performed in patients with nonalcoholic fatty liver disease (NAFLD). We used a quantitative method based on the hepatic volume acquired from gadoxetate disodium-enhanced (Gd-EOB-DTPA-enhanced)...
Advanced Colonic Neoplasia at Follow-up Colonoscopy According to Risk Components and Adenoma Location at Index Colonoscopy: A Retrospective Study of 1,974 Asymptomatic Koreans

Baik SJ, Park H, Park JJ, Lee HJ, Jo SY, Park YM, Lee HS

  • Gut Liver.
  • 2017 Sep;11(5):667-673.
  • doi: 10.5009/gnl16402
BACKGROUND/AIMS: We aimed to estimate the cumulative incidence of advanced colonic neoplasia and analyze the risk factors for advanced colonic neoplasia according to risk components and adenoma location at index...
Heme Oxygenase-1 Induction and Anti-inflammatory Actions of Atractylodes macrocephala and Taraxacum herba Extracts Prevented Colitis and Was More Effective than Sulfasalazine in Preventing Relapse

Han KH, Park JM, Jeong M, Han YM, Go EJ, Park J, Kim H, Han JG, Kwon O, Hahm KB

  • Gut Liver.
  • 2017 Sep;11(5):655-666.
  • doi: 10.5009/gnl16496
BACKGROUND/AIMS: In inflammatory bowel disease (IBD), repeated bouts of remission and relapse occur in patients and can impose a risk of colitis-associated cancer. We hypothesized that plant extracts of Atractylodes...
In Vitro Activity of Diphenyleneiodonium toward Multidrug-Resistant Helicobacter pylori Strains

Chung JW, Kim SY, Park HJ, Chung CS, Lee HW, Lee SM, Kim I, Pak JH, Lee GH, Jeong JY

  • Gut Liver.
  • 2017 Sep;11(5):648-654.
  • doi: 10.5009/gnl16503
BACKGROUND/AIMS: The increased resistance of Helicobacter pylori to antibiotics has increased the need to develop new treatments for this bacterium. The aim of our study was to identify new drugs...
Comparison of the Outcomes of Peroral Endoscopic Myotomy for Achalasia According to Manometric Subtype

Kim WH, Cho JY, Ko WJ, Hong SP, Hahm KB, Cho JH, Lee TH, Hong SJ

  • Gut Liver.
  • 2017 Sep;11(5):642-647.
  • doi: 10.5009/gnl16545
BACKGROUND/AIMS: We evaluated whether manometric subtype is associated with treatment outcome in patients with achalasia treated by peroral endoscopic myotomy (POEM). METHODS: High-resolution manometry data and Eckardt scores were collected from...
Postoperative Helicobacter pylori Infection as a Prognostic Factor for Gastric Cancer Patients after Curative Resection

Jung DH, Lee YC, Kim JH, Chung H, Park JC, Shin SK, Lee SK, Kim HI, Hyung WJ, Noh SH

  • Gut Liver.
  • 2017 Sep;11(5):635-641.
  • doi: 10.5009/gnl16397
BACKGROUND/AIMS: Few studies have evaluated the effect of Helicobacter pylori infection on the prognosis of patients diagnosed with gastric cancer (GC) after curative surgery. We investigated the association between the...
Characteristics of Primary and Metachronous Gastric Cancers Discovered after Helicobacter pylori Eradication: A Multicenter Propensity Score-Matched Study

Maehata Y, Nakamura S, Esaki M, Ikeda F, Moriyama T, Hida R, Washio E, Umeno J, Hirahashi , Kitazono T, Matsumoto

  • Gut Liver.
  • 2017 Sep;11(5):628-634.
  • doi: 10.5009/gnl16357
BACKGROUND/AIMS: Gastric cancers develop even after successful Helicobacter pylori eradication. We aimed to clarify the characteristics of early gastric cancers discovered after H. pylori eradication. METHODS: A total of 1,053 patients...
Endoscopic Submucosal Tunnel Dissection for Upper Gastrointestinal Submucosal Tumors Originating from the Muscularis Propria Layer: A Single-Center Study

Tang X, Ren Y, Huang S, Gao Q, Zhou J, Wei Z, Jiang B, Gong W

  • Gut Liver.
  • 2017 Sep;11(5):620-627.
  • doi: 10.5009/gnl15424
BACKGROUND/AIMS: In recent years, endoscopic submucosal tunnel dissection (ESTD) has gained popularity worldwide. The aim of this study was to evaluate the safety and efficacy of ESTD in treating upper...
Risk Factors for Gastric Tumorigenesis in Underlying Gastric Mucosal Atrophy

Song JH, Kim SG, Jin EH, Lim JH, Yang SY

  • Gut Liver.
  • 2017 Sep;11(5):612-619.
  • doi: 10.5009/gnl16488
BACKGROUND/AIMS: Atrophic gastritis is considered a premalignant lesion. We aimed to evaluate the risk factors for gastric tumorigenesis in underlying mucosal atrophy. METHODS: A total of 10,185 subjects who underwent upper...
Endoscopic Management of Peri-Pancreatic Fluid Collections

Yip HC, Teoh AY

  • Gut Liver.
  • 2017 Sep;11(5):604-611.
  • doi: 10.5009/gnl16178
In the past decade, there has been a progressive paradigm shift in the management of peri-pancreatic fluid collections after acute pancreatitis. Refinements in the definitions of fluid collections from the...
Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives

Su TH, Liu CJ

  • Gut Liver.
  • 2017 Sep;11(5):590-603.
  • doi: 10.5009/gnl16215
Nucleos(t)ide analogues (NUCs) and interferon have been used for several decades to treat chronic hepatitis B; however, the therapeutic response remains unsatisfactory. Although NUC therapy exhibits potent on-treatment viral suppression,...
Gastroparesis Updates on Pathogenesis and Management

Liu N, Abell T

  • Gut Liver.
  • 2017 Sep;11(5):579-589.
  • doi: 10.5009/gnl16336
Gastroparesis (Gp) is a chronic disease that presents with clinical symptoms of early satiety, bloating, nausea, vomiting, and abdominal pain. Along with these symptoms, an objective finding of delayed gastric...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr